Functional Roles of Neuroimmune Factors in Mediating Behavior. Ethanol abuse at all life-stages can result in significant disability, and alcoholism has tremendous personal and societal consequences. Ethanol abuse at each of these life-stages is associated with inflammation in the central nervous system (CNS). This may contribute to neurodegeneration and impaired neurological function associated with excessive alcohol consumption. In addition, intriguing recent studies demonstrate that pro- inflammatory molecules including cytokines and chemokines modulate addiction to alcohol, which has resulted in a paradigm shift linking immune response to addictive behavior. The proposed studies will address a critical gap in our knowledge concerning the role of neuroinflammation in mediating ethanol-induced neurodegeneration throughout life. The general hypothesis of the proposed studies is that toll-like receptors (TLRs) expressed by resident CNS microglia respond to """"""""danger signals"""""""" produced following ethanol exposure in the CNS resulting in the production of pro-inflammatory cytokines and chemokines that both modulate neurodegeneration as well as alcohol addiction. This will be tested in parallel in mice in vivo and in vitro in primary cultures, utilizing animals with targeted deletion of key TLR signaling molecules.
f Specific Aim 1 : Determine the mechanisms by which microglial TLRs modulate response to ethanol and neurodegeneration.
f Specific Aim 2 : Determine the effects of TLRs in modulating ethanol-induced neurodegeneration in vivo at different life-stages.
f Specific Aim 3 : Determine the effects of TLRs in modulating ethanol-induced neuroinflammation in vivo at different life-stages.

Public Health Relevance

The proposed studies will determine the mechanisms by which TLRs expressed by microglia modulate ethanol induced neurodegeneration in the nervous system at different life-stages. These studies may have important implications concerning treatments designed to protect the brain from toxic effects of ethanol as well as

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
NIH Challenge Grants and Partnerships Program (RC1)
Project #
5RC1AA019108-02
Application #
7937103
Study Section
Special Emphasis Panel (ZRG1-IFCN-A (58))
Program Officer
Cui, Changhai
Project Start
2009-09-25
Project End
2013-05-31
Budget Start
2010-09-01
Budget End
2013-05-31
Support Year
2
Fiscal Year
2010
Total Cost
$499,999
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
122452563
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Cippitelli, Andrea; Domi, Esi; Ubaldi, Massimo et al. (2017) Protection against alcohol-induced neuronal and cognitive damage by the PPAR? receptor agonist pioglitazone. Brain Behav Immun 64:320-329
Drew, Paul D; Johnson, Jennifer W; Douglas, James C et al. (2015) Pioglitazone blocks ethanol induction of microglial activation and immune responses in the hippocampus, cerebellum, and cerebral cortex in a mouse model of fetal alcohol spectrum disorders. Alcohol Clin Exp Res 39:445-54
Drew, Paul D; Kane, Cynthia J M (2014) Fetal alcohol spectrum disorders and neuroimmune changes. Int Rev Neurobiol 118:41-80
Kane, Cynthia J M; Phelan, Kevin D; Douglas, James C et al. (2014) Effects of ethanol on immune response in the brain: region-specific changes in adolescent versus adult mice. Alcohol Clin Exp Res 38:384-91
Kane, Cynthia J M; Phelan, Kevin D; Douglas, James C et al. (2013) Effects of ethanol on immune response in the brain: region-specific changes in aged mice. J Neuroinflammation 10:66
Kane, Cynthia J M; Phelan, Kevin D; Drew, Paul D (2012) Neuroimmune mechanisms in fetal alcohol spectrum disorder. Dev Neurobiol 72:1302-16
Kane, Cynthia J M; Phelan, Kevin D; Han, Lihong et al. (2011) Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-? agonists. Brain Behav Immun 25 Suppl 1:S137-45